Literature DB >> 35076678

Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.

Joel G Ray1, Kasim E Abdulaziz2, Howard Berger3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35076678      PMCID： PMC8790661          DOI： 10.1001/jama.2021.22749

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  6 in total

1.  Low Rates of Aspirin Use for the Prevention of Preeclampsia.

Authors:  Effie Viguiliouk; Alison L Park; Howard Berger; Michael P Geary; Joel G Ray
Journal:  J Obstet Gynaecol Can       Date:  2017-06-16

2.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

3.  Prevalence of Pre-Pregnancy Diabetes, Obesity, and Hypertension in Canada.

Authors:  Howard Berger; Nir Melamed; Beth Murray-Davis; Haroon Hasan; Karizma Mawjee; Jon Barrett; Sarah D McDonald; Michael Geary; Joel G Ray
Journal:  J Obstet Gynaecol Can       Date:  2019-03-23

4.  Use of a Smartphone App to Explore Potential Underuse of Prophylactic Aspirin for Preeclampsia.

Authors:  Tamar Krishnamurti; Alexander L Davis; Samantha Rodriguez; Laila Hayani; Miriam Bernard; Hyagriv N Simhan
Journal:  JAMA Netw Open       Date:  2021-10-01

Review 5.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.

Authors:  Emily Bartsch; Karyn E Medcalf; Alison L Park; Joel G Ray
Journal:  BMJ       Date:  2016-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.